Drug: KALETRA Injury: Maternal exposure during pregnancy Quarter: 2016Q3
Total Records: 5 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
65328013 | KALETRA | Maternal exposure during pregnancy | BRISTOL MYERS SQUIBB | 38.84 YR | F | 0 | 20160824 | FR |
74083925 | KALETRA | Maternal exposure during pregnancy | BRISTOL MYERS SQUIBB | 31.00 YR | F | 0 | 20160824 | FR |
97612453 | KALETRA | Maternal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 | F | 0 | 20160726 | JP |
114130653 | KALETRA | Maternal exposure during pregnancy | BRISTOL MYERS SQUIBB | 38.00 YR | F | 0 | 20160720 | AR |
118710692 | KALETRA | Maternal exposure during pregnancy | BRISTOL MYERS SQUIBB | 26.00 YR | F | 0 | 20160825 | US |
Total Records: 5 Number of Pages: 1